Clinical trial
12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
NCT00735007
Study timeline
Study start (unknown)2008-07-01Date precision: month
Registry last updated2013-11-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
EMD Seronolead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00735007 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.